CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial 期刊论文
2018, 卷号: 6, 期号: 9, 页码: 681-690
作者:  Wang, Zhijie;  Cheng, Ying;  An, Tongtong;  Gao, Hongjun;  Wang, Kai
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/03
Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) 期刊论文
2017, 卷号: 12, 期号: 12, 页码: 1766-1778
作者:  Zhong, Jia;  Li, Lei;  Wang, Zhijie;  Bai, Hua;  Gai, Fei
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/03
A cis-eQTL genetic variant of the cancer-testis gene CCDC116 is associated with risk of multiple cancers 期刊论文
2017, 卷号: 136, 期号: 8, 页码: 987-997
作者:  Qin, Na;  Wang, Cheng;  Lu, Qun;  Huang, Tongtong;  Zhu, Meng
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace